The uncorrected proofs of our new paper:
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning. Dorman et al. Mol. Oncol. 2015
DOI: 10.1016/j.molonc.2015.07.006
are now available online at this link (http://dx.doi.org/10.1016/j.